Veracyte Inc
(FRA:12V)
€
39.4
0.8 (2.07%)
Market Cap: 3.16 Bil
Enterprise Value: 2.92 Bil
PE Ratio: 0
PB Ratio: 2.76
GF Score: 81/100 Veracyte Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2021 / 03:30PM GMT
Release Date Price:
€28
(-4.76%)
Brandon Couillard
(Trades, Portfolio) LLC - Analyst
Alright, good morning. Welcome, everybody, to the Jefferies 2021 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the tools and diagnostics space. Very happy to have Veracyte with us at the conference again this year.
Joining us from the Company, Cofounder and now Executive Chairwoman, Bonnie Anderson; and newly appointed CEO, who just took over the reins this week, Marc Stapley.
I feel like there's so much going on here. It feels like there's a major new piece of news out of Veracyte every other week whether that's the Decipher deal, Percepta, nasal swab data, Bonnie's transition after 13 or 14 years, and another very interesting acquisition just earlier this week. So happy you are here to break it all down for us
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot